Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaK is the major bacterial homolog of the heat shock protein 70 (Hsp70) family. It functions as a molecular chaperone, facilitating the folding and refolding of proteins, preventing aggregation under stress, and maintaining overall proteome stability[1][3][4][5][6]. DnaK cycles between ATP- and ADP-bound states, working in concert with co-chaperones DnaJ (J-domain protein) and GrpE (nucleotide exchange factor) to bind client proteins, stimulate ATP hydrolysis, and promote proper folding[2][3][5]. Highly conserved across bacteria, DnaK is essential under heat and chemical stress and is required for the growth and virulence of many pathogenic species[3][5]. Recent research highlights DnaK as a promising antibacterial target, as small-molecule and peptide-based inhibitors can disrupt its activity, potentially sensitizing bacteria to conventional antibiotics or inhibiting the evolution of resistance[3]. DnaK's role in proteostasis, stress response, and pathogenesis make it a central therapeutic target and a key player in bacterial cell biology[1][3][5].
Inhibition of ATPase activity (blocks chaperone function required for protein folding); Disruption of substrate binding (interferes with interaction between DnaK and misfolded/unfolded proteins); Synergism with antibiotics (inhibition of DnaK can potentiate effects of existing antibiotics); Disruption of interaction with co-chaperones DnaJ and GrpE (essential for chaperone cycle)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 70 kilodalton heat shock protein (bacterial Hsp70 homolog) (DnaK).